← FDA Drug Approvals (Drugs@FDA)

LEXAPRO

NDA · New Drug Application · Sponsor: ABBVIE · Approved 2002-11-27

Drug application

FDA Application #

NDA021365

Application type

New Drug Application

Brand name

LEXAPRO

Generic name

Escitalopram Oxalate

Active ingredients

ESCITALOPRAM OXALATE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Discontinued

Sponsor

ABBVIE

First approval

2002-11-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown